News & Updates
Filter by Specialty:
Serious infections prevalent in RTX-treated patients with SLE
A recent study has reported the prevalence of serious infection (SI) among patients with systemic lupus erythematosus (SLE) following treatment with rituximab (RTX).
Serious infections prevalent in RTX-treated patients with SLE
13 Feb 2024
Is BASDAI a responsive instrument in PsA?
Use of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) as an instrument in psoriatic arthritis (PsA) demonstrates “reasonable” responsiveness but falls short of distinguishing peripheral PsA from axial (ax)PsA, according to a recent study.
Is BASDAI a responsive instrument in PsA?
13 Feb 2024
Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.
Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
13 Feb 2024
IV ginkgo may boost brain recovery after stroke
In a placebo-controlled trial, active components of Ginkgo biloba given intravenously for 14 days helps improve cognitive recovery among patients following an acute ischaemic stroke.
IV ginkgo may boost brain recovery after stroke
13 Feb 2024
Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids
For people with overweight or obesity and type 2 diabetes, intensive lifestyle intervention appears to minimize the spikes and drops in cardiovascular risk factors such as blood glucose and lipids.